Hong Lee Heng

机构：National Cancer Centre Singapore

发表论文 40 篇 · 总被引 2769 次 · h-index 11

代表论文

• Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches (2024 · Cancers · 被引 42)
• PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma (2023 · Nature Cell Biology · 被引 25)
• Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies (2023 · Gut · 被引 23)
• PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinoma (2025 · International Journal of Biological Sciences · 被引 9)
• Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway (2025 · Biomedicine & Pharmacotherapy · 被引 6)
• Functional characterisation guides classification of novel BAP1 germline variants (2020 · npj Genomic Medicine · 被引 6)